SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?


To: Iamarangerboy who wrote (9497)6/13/2006 9:43:25 AM
From: Iamarangerboy  Read Replies (1) | Respond to of 10280
 
tradingmarkets.com

Sepracor Reports Presentation Of LUNESTA Data - Quick Facts

Tuesday, June 13, 2006; Posted: 07:19 AM

(RTTNews) - Sepracor Inc. (SEPR | charts | news | PowerRating) said data for LUNESTA brand eszopiclone will be presented at the SLEEP 2006 20th Anniversary Meeting of the Associated Professional Sleep Societies at the Salt Palace Convention Center in Salt Lake City on June 20th and 22nd. LUNESTA is indicated for the treatment of insomnia. LUNESTA is not indicated for the treatment of rheumatoid arthritis, menopause or depression.